{
    "eid": "2-s2.0-85109766967",
    "title": "Variation in Peritoneal Dialysis\u2013Related Peritonitis Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "End-stage renal disease (ESRD)",
        "facility practices",
        "microbiology",
        "peritoneal dialysis (PD)",
        "Peritoneal Dialysis and Outcomes Practice Patterns Study (PDOPPS)",
        "peritoneal dialysis-associated peritonitis",
        "peritonitis outcomes",
        "peritonitis-dialysis related infection"
    ],
    "authors": [
        "Muthana Al Sahlawi",
        "Junhui Zhao",
        "Keith McCullough",
        "Douglas S. Fuller",
        "Neil Boudville",
        "Yasuhiko Ito",
        "Talerngsak Kanjanabuch",
        "Sharon J. Nessim",
        "Beth M. Piraino",
        "Ronald L. Pisoni",
        "Isaac Teitelbaum",
        "Graham Woodrow",
        "Hideki Kawanishi",
        "David W. Johnson",
        "Jeffrey Perl"
    ],
    "citedby-count": 21,
    "ref-count": 45,
    "ref-list": [
        "The current state of peritoneal dialysis",
        "Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis",
        "Recent peritonitis associates with mortality among patients treated with peritoneal dialysis",
        "Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients",
        "Microbiology and outcomes of peritonitis in North America",
        "The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients",
        "Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000-2007)",
        "Prevention of peritoneal dialysis-related infections",
        "Prevention of peritoneal dialysis-related infections",
        "Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases",
        "Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes",
        "Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study",
        "Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases",
        "Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases",
        "Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases",
        "Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases",
        "Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis",
        "Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases",
        "The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis",
        "Optimizing peritoneal dialysis-associated peritonitis prevention in the United States: from standardized peritoneal dialysis-associated peritonitis reporting and beyond",
        "ISPD peritonitis recommendations: 2016 update on prevention and treatment",
        "A multivariate technique for multiply imputing missing values using a sequence of regression models",
        "Multiple imputation for nonresponse in surveys [book review]",
        "Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database",
        "Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)",
        "Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis",
        "The outcome of peritonitis in patients on automated peritoneal dialysis",
        "Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease",
        "The association between peritoneal dialysis modality and peritonitis",
        "Review of antibiotic dosing with peritonitis in APD",
        "Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study)",
        "Stability of drug additives in peritoneal dialysis solutions in a new container",
        "Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis",
        "Biocompatible dialysis fluids for peritoneal dialysis",
        "The mutual relationship between peritonitis and peritoneal transport",
        "The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients",
        "The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial",
        "Residual kidney function and peritoneal dialysis-associated peritonitis treatment outcomes",
        "Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients",
        "Escherichia coli peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center",
        "Relapsing peritonitis in children who undergo chronic peritoneal dialysis: a prospective study of the international pediatric peritonitis registry",
        "Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function",
        "Empirical aminoglycosides for peritonitis do not affect residual renal function",
        "Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function",
        "The Relationship Between Presentation and the Time of Initial Administration of Antibiotics With Outcomes of Peritonitis in Peritoneal Dialysis Patients: The PROMPT Study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hiroshima",
            "@id": "60254871",
            "affilname": "Tsuchiya General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60254871",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Ann Arbor",
            "@id": "60136265",
            "affilname": "Arbor Research Collaborative for Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60136265",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Woolloongabba",
            "@id": "60109259",
            "affilname": "Translational Research Institute Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109259",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60085801",
            "affilname": "Li Ka Shing Knowledge Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60085801",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Perth",
            "@id": "60031806",
            "affilname": "The University of Western Australia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031806",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Brisbane",
            "@id": "60031004",
            "affilname": "The University of Queensland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031004",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Al-Ahsa",
            "@id": "60030736",
            "affilname": "King Faisal University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030736",
            "affiliation-country": "Saudi Arabia"
        },
        {
            "affiliation-city": "Aurora",
            "@id": "60028392",
            "affilname": "University of Colorado Anschutz Medical Campus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028392",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Woolloongabba",
            "@id": "60025258",
            "affilname": "Princess Alexandra Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025258",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Leeds",
            "@id": "60020454",
            "affilname": "St James's University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020454",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Montreal",
            "@id": "60018916",
            "affilname": "Sir Mortimer B. Davis Jewish General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018916",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Pittsburgh",
            "@id": "60015543",
            "affilname": "University of Pittsburgh",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015543",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nagakute",
            "@id": "60004395",
            "affilname": "Aichi Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004395",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Akebia Therapeutics",
        "Horizon Therapeutics USA, Inc",
        "Nikkiso Co Ltd",
        "Thailand Research Foundation",
        "US National Institutes of Health",
        "US Department of Health and Human Services",
        "Agency for Healthcare Research and Quality",
        "Amgen",
        "Kidney Foundation",
        "AstraZeneca",
        "Roche",
        "Baxter Healthcare",
        "King Chulalongkorn Memorial Hospital",
        "HHS",
        "Merck Sharp & Dohme",
        "National Institute for Health Research",
        "National Health and Medical Research Council",
        "Chulalongkorn University",
        "National Research Council of Thailand"
    ]
}